The stock of Cue Health Inc. (NASDAQ:HLTH) last traded at $2.08, up 20.93% from the previous session.
HLTH stock price is now -34.19% away from the 50-day moving average and -51.50% away from the 200-day moving average. The market capitalization of the company currently stands at $343.57M.
In other news, Sever Clint, Chief Product Officer sold 29,269 shares of the company’s stock on Dec 08. The stock was sold for $88,334 at an average price of $3.02. Upon completion of the transaction, the Chief Product Officer now directly owns 3,939,647 shares in the company, valued at $8.19 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 07, Chief Product Officer Sever Clint sold 24,147 shares of the business’s stock. A total of $71,958 was realized by selling the stock at an average price of $2.98. This leaves the insider owning 3,939,647 shares of the company worth $8.19 million. Insiders disposed of 1,515,040 shares of company stock worth roughly $3.15 million over the past 1 year. A total of 12.80% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in HLTH stock. A new stake in Cue Health Inc. shares was purchased by ACME, LLC during the first quarter worth $31,700,000. BALYASNY ASSET MANAGEMENT LLC invested $448,000 in shares of HLTH during the first quarter. In the first quarter, JANNEY MONTGOMERY SCOTT LLC acquired a new stake in Cue Health Inc. valued at approximately $166,000. STATE OF WYOMING acquired a new stake in HLTH for approximately $93,000. PARAMETRIC PORTFOLIO ASSOCIATES LLC purchased a new stake in HLTH valued at around $68,000 in the second quarter. In total, there are 136 active investors with 55.20% ownership of the company’s stock.
With an opening price of $1.7000 on Thursday morning, Cue Health Inc. (NASDAQ: HLTH) set off the trading day. During the past 12 months, Cue Health Inc. has had a low of $1.68 and a high of $14.90. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 3.00, and a quick ratio of 2.20. The fifty day moving average price for HLTH is $3.1604 and a two-hundred day moving average price translates $4.2884 for the stock.
The latest earnings results from Cue Health Inc. (NASDAQ: HLTH) was released for Jun, 2022. According to the Health Information Services Company, earnings per share came in at -$0.67, missing analysts’ expectations of -$0.46 by -0.21. This compares to $0.49 EPS in the same period last year. The net profit margin was -24.20% and return on equity was -19.30% for HLTH. The company reported revenue of $69.59 million for the quarter, compared to $223.68 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -68.89 percent. For the current quarter, analysts expect HLTH to generate $58.16M in revenue.
Cue Health Inc.(HLTH) Company Profile
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.